Alternatives to Generate Biomedicines

Generative AI-designed enzymes for pharma manufacturing and life science tools

End-to-end generative AI drug discovery platform from target ID to clinical trials, validated by a Phase III pipeline.

Generative AI and robotics for autonomous drug discovery, compressing the DMTA cycle to under two years.

Causal AI for human health, turning 20+ petabytes of cellular data into targeted therapeutics.

ML-guided protein engineering platform for multi-property co-optimization with compounding models from your own experimental data

Automated cloud lab to validate protein designs in under 3 weeks.

Open-source full-atom peptide design with geometric latent diffusion, conditioned on protein pockets.

AI-enabled antimicrobial peptides from milk proteins for infectious diseases

AI target discovery platform for neurotherapeutics across disorders

AI-designed multivalent nanoparticles for cell-selective drug delivery

Open-source automated model assembly from literature and databases for systems biology

Lineage-native, format-agnostic lakehouse for traceable, multimodal AI in biology.

AI-native drug discovery partner building on AlphaFold for pharma R&D.

Owkin's K Pro: an autonomous AI scientist for biopharma R&D decision-making

AI-native drug discovery: phenomics, robotics, and a 50+ petabyte dataset to de-risk medicines.

Tech-driven drug discovery and biologics manufacturing platform

Mechanistic interpretability platform to understand, debug, and design AI models

Highly selective small-molecule drug discovery for oncology, immunology, and metabolic diseases.

AI superplatform for ultra-fast small-molecule drug discovery in immune diseases

Oncology real-world evidence platform turning patient data into AI-powered insights for cancer research and care.

All-in-human AI foundation models for precision neurology and CNS drug discovery

AI-driven clinical trial patient matching and recruitment from EMR data.

Physics-based molecular discovery platform for drug and materials design

Cloud ELN, LIMS, and AI platform that unifies biotech R&D data.

FDA-cleared AI for cancer pathology diagnostics and biomarker discovery.

Regulatory-cleared quantitative imaging biomarkers from MRI, CT, and PET for radiology and biopharma

Google's AI ecosystem for health research, clinical tools, and consumer well-being.

AI-powered precision oncology platform analyzing clinical and molecular data for personalized cancer care.

AI-native biotech accelerating small-molecule drug discovery from design to clinic

AI-driven biomanufacturing for personalized stem cell therapies